03475v10 News Today

AngioDynamics, Inc. (NASDAQ:ANGO – Get Free Report) CEO James C. Clemmer purchased 10,000 shares of the firm’s stock in a transaction that occurred on Monday, April 8th. The shares were acquired at an average cost of $6.70 per share, for a total transaction of $67,000.00. Following the purchase, the chief executive officer now owns 539,066 […]

Oppenheimer upgraded shares of AngioDynamics (NASDAQ:ANGO – Free Report) from a market perform rating to an outperform rating in a report released on Friday morning, Marketbeat reports. Oppenheimer currently has $12.00 target price on the medical instruments supplier’s stock. A number of other analysts also recently issued reports on ANGO. Raymond James reduced their price […]

Oppenheimer upgraded shares of AngioDynamics (NASDAQ:ANGO – Free Report) from a market perform rating to an outperform rating in a report issued on Friday, Marketbeat Ratings reports. Oppenheimer currently has $12.00 price target on the medical instruments supplier’s stock. A number of other brokerages have also recently weighed in on ANGO. Raymond James reduced their […]

AngioDynamics (NASDAQ:ANGO – Get Free Report) and Alpha Tau Medical (NASDAQ:DRTS – Get Free Report) are both small-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their dividends, valuation, institutional ownership, analyst recommendations, earnings, risk and profitability. Earnings & Valuation This table compares AngioDynamics […]

AngioDynamics, Inc. (NASDAQ:ANGO – Get Free Report) was the recipient of a large increase in short interest in the month of January. As of January 31st, there was short interest totalling 2,180,000 shares, an increase of 26.0% from the January 15th total of 1,730,000 shares. Based on an average daily trading volume, of 524,800 shares, […]

AngioDynamics, Inc. (NASDAQ:ANGO – Get Free Report) was the target of a large growth in short interest in the month of January. As of January 15th, there was short interest totalling 1,730,000 shares, a growth of 18.5% from the December 31st total of 1,460,000 shares. Based on an average trading volume of 583,400 shares, the […]

AngioDynamics (NASDAQ:ANGO – Free Report) had its price target cut by HC Wainwright from $20.00 to $18.00 in a research note released on Monday, Benzinga reports. They currently have a buy rating on the medical instruments supplier’s stock. HC Wainwright also issued estimates for AngioDynamics’ Q3 2024 earnings at ($0.12) EPS, Q4 2024 earnings at […]

AngioDynamics (NASDAQ:ANGO – Get Free Report) updated its FY 2024 earnings guidance on Friday. The company provided earnings per share guidance of -0.420–0.350 for the period, compared to the consensus earnings per share estimate of -0.320. The company issued revenue guidance of $320.0 million-$325.0 million, compared to the consensus revenue estimate of $329.1 million. AngioDynamics […]

AngioDynamics (NASDAQ:ANGO – Get Free Report) issued an update on its second quarter earnings guidance on Friday morning. The company provided earnings per share (EPS) guidance of ($0.05) for the period, compared to the consensus estimate of ($0.08). The company issued revenue guidance of $79.1 million, compared to the consensus revenue estimate of $81.95 million. […]

AngioDynamics, Inc. (NASDAQ:ANGO – Free Report) – Analysts at HC Wainwright reduced their Q2 2024 earnings estimates for shares of AngioDynamics in a research report issued to clients and investors on Thursday, October 5th. HC Wainwright analyst Y. Chen now anticipates that the medical instruments supplier will post earnings of ($0.08) per share for the […]